Sonoma Pharmaceuticals, Inc. Stock Agreements
12 Contracts & Agreements
- SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022 (Filed With SEC on December 30, 2022)
- Specimen Common Stock Certificate (Filed With SEC on June 28, 2017)
- OCULUS INNOVATIVE SCIENCES, INC. Common Stock (par value $0.0001 per share) At-the-Market Issuance Sales Agreement (Filed With SEC on April 2, 2014)
- OCULUS INNOVATIVE SCIENCES, INC. CERTIFICATE OF DESIGNATIONOF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A 0% CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151OF THE DELAWARE... (Filed With SEC on April 25, 2012)
- WARRANTTO PURCHASE SHARES OFCOMMON STOCK OF OCULUSINNOVATIVE SCIENCES, INC. (Voidafter November 30, 2017) _______________________________________________ (Filed With SEC on May 6, 2010)
- Common stock outstanding as of July 17, 2009 (Filed With SEC on July 21, 2009)
- Common stock outstanding as of July 17, 2009 (Filed With SEC on July 21, 2009)
- Common stock outstanding as of June 15, 2009 (Filed With SEC on July 9, 2009)
- Common stock outstanding as of June 15, 2009 (Filed With SEC on July 9, 2009)
- Common stock outstanding as of June 15, 2009 (Filed With SEC on June 17, 2009)
- Common stock outstanding as of April 2, 2009 (Filed With SEC on April 10, 2009)
- One hundred shares of our common stock, par value $0.0001 per share (Filed With SEC on February 9, 2009)
